Loading...
Bienvenue sur la collection HAL du laboratoire de BECCOH
Quelques conseils pour une publication "idéHALe"
• Pensez à respecter la signature institutionnelle
Université Paris-Saclay, UVSQ, BECCOH, 92104, Boulogne-Billancourt, France..
• Participez à l'accès ouvert
N'attendez pas : dès que votre article est en ligne, déposez dans Hal sa version acceptée pour publication et indiquez un embargo de 6 mois.
La loi pour une république numérique vous autorise en effet à partager cette version 6 mois après publications, quelque-soit l'éditeur
Plus d'informations Archives Ouverte : quid de mes droits d'auteurs ?
• Vous souhaitez disposer d'une page web référençant toutes vos publications ?
Créez vous en 5 minutes un idHal et un CVHAL
N'hésitez pas à nous contacter pour toutes questions,
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
Dernières Publications en accès ouvert dans Hal
-
-
-
-
-
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
-
Alexandra Kachaner, Raphaèle Seror, Fleur Cohen Aubart, Julien Henry, Thierry Lazure, et al.. Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature. JBMR Plus, 2024, 8 (5), pp.ziae043. ⟨10.1093/jbmrpl/ziae043⟩. ⟨hal-04626829⟩
-
Robin Zagala, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbe, et al.. Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology, In press, ⟨10.1111/jdv.20155⟩. ⟨hal-04626767⟩
-
Johanne Seguin, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, et al.. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics, 2024, 16 (3), pp.315. ⟨10.3390/pharmaceutics16030315⟩. ⟨hal-04626840⟩
-
-
Julie Lecuelle, Caroline Truntzer, Debora Basile, Luigi Laghi, Luana Greco, et al.. Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts. EBioMedicine, 2024, 105, pp.105207. ⟨10.1016/j.ebiom.2024.105207⟩. ⟨hal-04626841⟩
Mots clés
Lung cancer
2-chlorodeoxyadenosine
Trametinib
Anti-PD1 blockade
Safety
AML
Dabrafenib
Systemic therapy
Osimertinib
Targeted therapy
Liver metastases
Chemoresistance
Adverse events
ADAMTS13
Chemotherapy
Immune checkpoint inhibitor
BRAF
Crizotinib
Locally advanced
ALK
Nivolumab
Metastatic cSCC
Anti-PD-1 antibody
Anti-CTLA-4 anti-PD-1 elderly immune checkpoint inhibitors melanoma nonagenarian octogenarian
Resistance
Mesenchymal stromal cells
ACTH
Molecular targeted therapies
Anti-PD-1
Surgical excision
Histiocytosis
Lung adenocarcinoma
Immunomodulation
Immunothérapie
Adjuvant
ADN tumoral circulant
Circulating cell-free DNA
Abdominal pain
Langerhans cell histiocytosis
TNM classification
Adjuvant therapy
Colorectal carcinoma
Biomarker
Cancer
Treatment
Prevention
Abscopal effect anti-PD-1 antibody melanoma nivolumab pembrolizumab radiotherapy
Radiotherapy
Angiosarcoma
Cutaneous squamous cell carcinoma
Prognosis
Assisted reproductive techniques
Advanced
Gastric bypass
Adapted physical activity molecular diagnosis oligometastatic disease pancreatic adenocarcinoma KRAS mutation
Toxicity
Radiofrequency ablation
Cemiplimab
COVID-19
Survival
Oncology
Immunotherapy
Diagnosis
Merkel cell carcinoma
Immunohistochemistry
EGFR
Allelic imbalance
Polyomavirus
ALK rearrangement
Children
Colon cancer
HIV
Antibody-drug conjugate
Wnt
Anti-Tumor pharmacology
Abscopal effect
Sonic Hedgehog
Follow-up
Advanced melanoma
Biomarkers
Acute generalized exanthematous pustulosis
Anti-CTLA-4
Non-small cell lung cancer
Cancer bronchique non à petites cellules
Antineoplastic agents
Metastatic
BRAF V600E
Thrombosis
Circulating tumor DNA
Adjuvant FOLFOX
AZD9291
Colorectal cancer
Anti-PD1
Androgen insensitivity
Invasive cutaneous squamous cell carcinoma
Plasma
Staging
BRAFV600E mutation
Prognostic
Melanoma
Carte des collaborations
Country | Number of publications |
---|